Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs LUPIN - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA LUPIN ALEMBIC PHARMA/
LUPIN
 
P/E (TTM) x 32.2 40.7 79.1% View Chart
P/BV x 4.4 6.0 73.8% View Chart
Dividend Yield % 0.8 0.2 329.4%  

Financials

 ALEMBIC PHARMA   LUPIN
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-23
LUPIN
Mar-23
ALEMBIC PHARMA/
LUPIN
5-Yr Chart
Click to enlarge
High Rs792799 99.2%   
Low Rs463583 79.5%   
Sales per share (Unadj.) Rs287.6365.8 78.6%  
Earnings per share (Unadj.) Rs17.49.8 176.8%  
Cash flow per share (Unadj.) Rs31.429.2 107.6%  
Dividends per share (Unadj.) Rs8.004.00 200.0%  
Avg Dividend yield %1.30.6 220.1%  
Book value per share (Unadj.) Rs222.3270.7 82.1%  
Shares outstanding (eoy) m196.56454.98 43.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.21.9 115.6%   
Avg P/E ratio x36.170.2 51.4%  
P/CF ratio (eoy) x20.023.7 84.5%  
Price / Book Value ratio x2.82.6 110.6%  
Dividend payout %46.040.7 113.1%   
Avg Mkt Cap Rs m123,402314,381 39.3%   
No. of employees `000NANA-   
Total wages/salary Rs m11,69130,872 37.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m56,526166,417 34.0%  
Other income Rs m301,509 2.0%   
Total revenues Rs m56,557167,926 33.7%   
Gross profit Rs m6,77217,206 39.4%  
Depreciation Rs m2,7548,807 31.3%   
Interest Rs m5022,743 18.3%   
Profit before tax Rs m3,5467,165 49.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1262,688 4.7%   
Profit after tax Rs m3,4204,477 76.4%  
Gross profit margin %12.010.3 115.9%  
Effective tax rate %3.637.5 9.5%   
Net profit margin %6.12.7 224.9%  
BALANCE SHEET DATA
Current assets Rs m29,139124,513 23.4%   
Current liabilities Rs m16,40892,654 17.7%   
Net working cap to sales %22.519.1 117.6%  
Current ratio x1.81.3 132.1%  
Inventory Days Days1026 37.0%  
Debtors Days Days798 6.9%  
Net fixed assets Rs m31,498103,490 30.4%   
Share capital Rs m393910 43.2%   
"Free" reserves Rs m43,312122,246 35.4%   
Net worth Rs m43,705123,156 35.5%   
Long term debt Rs m0275 0.0%   
Total assets Rs m60,637228,003 26.6%  
Interest coverage x8.13.6 223.4%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.90.7 127.7%   
Return on assets %6.53.2 204.2%  
Return on equity %7.83.6 215.3%  
Return on capital %9.38.0 115.4%  
Exports to sales %46.40-   
Imports to sales %12.10-   
Exports (fob) Rs m26,210NA-   
Imports (cif) Rs m6,846NA-   
Fx inflow Rs m26,21048,057 54.5%   
Fx outflow Rs m6,84621,752 31.5%   
Net fx Rs m19,36426,306 73.6%   
CASH FLOW
From Operations Rs m7,24018,972 38.2%  
From Investments Rs m-4,476-12,868 34.8%  
From Financial Activity Rs m-2,620-3,373 77.7%  
Net Cashflow Rs m1442,732 5.3%  

Share Holding

Indian Promoters % 69.1 46.8 147.8%  
Foreign collaborators % 0.5 0.3 182.1%  
Indian inst/Mut Fund % 19.0 45.8 41.5%  
FIIs % 4.5 16.1 28.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 53.0 57.4%  
Shareholders   85,212 281,542 30.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on ALEMBIC PHARMA vs Lupin

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALEMBIC PHARMA vs Lupin Share Price Performance

Period ALEMBIC PHARMA Lupin S&P BSE HEALTHCARE
1-Day -0.15% 1.23% 1.18%
1-Month -4.30% 0.15% -0.75%
1-Year 105.43% 151.14% 61.82%
3-Year CAGR 0.89% 17.13% 18.16%
5-Year CAGR 13.56% 17.42% 19.79%

* Compound Annual Growth Rate

Here are more details on the ALEMBIC PHARMA share price and the Lupin share price.

Moving on to shareholding structures...

The promoters of ALEMBIC PHARMA hold a 69.6% stake in the company. In case of Lupin the stake stands at 47.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALEMBIC PHARMA and the shareholding pattern of Lupin.

Finally, a word on dividends...

In the most recent financial year, ALEMBIC PHARMA paid a dividend of Rs 8.0 per share. This amounted to a Dividend Payout ratio of 46.0%.

Lupin paid Rs 4.0, and its dividend payout ratio stood at 40.7%.

You may visit here to review the dividend history of ALEMBIC PHARMA, and the dividend history of Lupin.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.